Laboratoire Riva Inc. Ranitidine Product Recall (2019-10-24)
· Published by Health Canada · Official notice
Alert type: Drug Recall
Category: Drugs
Issue: Product Safety
Audience: General Public, Healthcare Professionals, Hospitals
Department: Health Canada
Hazard classification: Type I
| Lot or serial number | Brand name | Companies | DIN, NPN, DIN-HIM | Dosage form | Strength |
|---|
| All lots | B. Riva-Ranitidine 150mg | - Recalling Firm
- Laboratoire Riva Inc.
- 660 Industriel Boulevard
- Blainville
- J7C 3V4
- Quebec
- CANADA
- Marketing Authorization Holder
- Laboratoire Riva Inc.
- 660 Industriel Boulevard
- Blainville
- J7C 3V4
- Quebec
- CANADA
| DIN 02247814 | Tablet | Ranitidine hydrochloride 150mg |
| All lots | C. Riva-Ranitidine 300mg | - Recalling Firm
- Laboratoire Riva Inc.
- 660 Industriel Boulevard
- Blainville
- J7C 3V4
- Quebec
- CANADA
- Marketing Authorization Holder
- Laboratoire Riva Inc.
- 660 Industriel Boulevard
- Blainville
- J7C 3V4
- Quebec
- CANADA
| DIN 02247815 | Tablet | Ranitidine hydrochloride 300mg |
| All lots | A. Acid Reducer 75mg | - Recalling Firm
- Laboratoire Riva Inc.
- 660 Industriel Boulevard
- Blainville
- J7C 3V4
- Quebec
- CANADA
- Marketing Authorization Holder
- Laboratoire Riva Inc.
- 660 Industriel Boulevard
- Blainville
- J7C 3V4
- Quebec
- CANADA
| DIN 02452464 | Tablet | Ranitidine hydrochloride 75mg |
-
Acid Reducer 75mg
-
Riva-Ranitidine 150mg
-
Riva-Ranitidine 300mg
Affected lots may be manufactured with an API containing an impurity, N-nitrosodimethylamine (NDMA)
Wholesalers, Healthcare Establishments, Retailers